Huntington National Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4 | Hold |
5,001
| – | – | ﹤0.01% | 4115 |
|
|
2026
Q1 | $16 | Hold |
5,001
| – | – | ﹤0.01% | 3587 |
|
|
2025
Q4 | $14 | Hold |
5,001
| – | – | ﹤0.01% | 3560 |
|
|
2025
Q3 | $19 | Hold |
5,001
| – | – | ﹤0.01% | 3467 |
|
|
2025
Q2 | $6 | Hold |
5,001
| – | – | ﹤0.01% | 3840 |
|
|
2025
Q1 | $4 | Hold |
5,001
| – | – | ﹤0.01% | 3921 |
|
|
2024
Q4 | $4 | Hold |
5,001
| – | – | ﹤0.01% | 3928 |
|
|
2024
Q3 | $20 | Hold |
5,001
| – | – | ﹤0.01% | 3489 |
|
|
2024
Q2 | $49 | Hold |
5,001
| – | – | ﹤0.01% | 2965 |
|
|
2024
Q1 | $40 | Hold |
5,001
| – | – | ﹤0.01% | 2921 |
|
|
2023
Q4 | $619 | Sell |
5,001
-10,000
| -67% | -$1.24K | ﹤0.01% | 2280 |
|
|
2023
Q3 | $1.41K | Sell |
15,001
-1,000
| -6% | -$94 | ﹤0.01% | 2150 |
|
|
2023
Q2 | $5.73K | Buy |
16,001
+2,000
| +14% | +$716 | ﹤0.01% | 1755 |
|
|
2023
Q1 | $5.04K | Buy |
14,001
+10,000
| +250% | +$8.96K | ﹤0.01% | 1724 |
|
|
2022
Q4 | $3.54K | Sell |
4,001
-2,000
| -33% | -$2.65K | ﹤0.01% | 1682 |
|
|
2022
Q3 | $9K | Hold |
6,001
| – | – | ﹤0.01% | 1583 |
|
|
2022
Q2 | $12K | Hold |
6,001
| – | – | ﹤0.01% | 1529 |
|
|
2022
Q1 | $14K | Hold |
6,001
| – | – | ﹤0.01% | 1491 |
|
|
2021
Q4 | $28K | Buy |
6,001
+1,000
| +20% | +$6.21K | ﹤0.01% | 1266 |
|
|
2021
Q3 | $38K | Hold |
5,001
| – | – | ﹤0.01% | 1058 |
|
|
2021
Q2 | $48K | Hold |
5,001
| – | – | ﹤0.01% | 971 |
|
|
2021
Q1 | $41K | Hold |
5,001
| – | – | ﹤0.01% | 907 |
|
|
2020
Q4 | $34K | Hold |
5,001
| – | – | ﹤0.01% | 934 |
|
|
2020
Q3 | $56K | Buy |
5,001
+3,000
| +150% | +$27.5K | ﹤0.01% | 759 |
|
|
2020
Q2 | $13K | Buy |
+2,001
| New | +$7.66K | ﹤0.01% | 1162 |
|
Other funds holding SRNE
Huntington National Bank's SRNE Position: Q2 2026 in Review
Huntington National Bank held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q2 2026 at 5,001 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #4115.
Huntington National Bank first reported a position in SRNE in Q2 2020 and has held it in 25 quarters since. The position peaked at $56K in Q3 2020. 5 funds tracked by Wall St. Rank hold SRNE as of Q2 2026.
- Huntington National Bank held 5,001 shares of Sorrento Therapeutics, Inc. worth $4 as of Q2 2026.
- Huntington National Bank left its Sorrento Therapeutics, Inc. share count unchanged in Q2 2026.
- Sorrento Therapeutics, Inc. made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #4115 holding.
- Huntington National Bank first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and has held it in 25 quarters since.
- Huntington National Bank's Sorrento Therapeutics, Inc. position peaked at $56K in Q3 2020.
- 5 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2026.
Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.